Psychiatric pharmacogenomics /
Mrazek, David.
Psychiatric pharmacogenomics / David A. Mrazek. - New York : Oxford University Press, 2010. - x, 265 p. : ill. (some col.) ; 25 cm.
Includes bibliographical references and index.
The language of molecular genetics -- The fourteen genes -- The problem and the solution -- The cytochrome P450 2D6 gene -- The cytochrome P450 2C19 gene -- The cytochrome P450 2C9 gene -- The cytochrome P450 1A2 gene -- The catechol-o-methyltransferase gene -- The norepinephrine transporter gene -- The dopamine transporter gene -- The serotonin transporter gene -- The serotonin 1A receptor gene -- The serotonin 2A receptor gene -- The serotonin 2C receptor gene -- The dopamine D2 receptor gene -- The dopamine D3 receptor gene -- The dopamine D4 receptor gene -- The clinical utility of psychiatric pharmacogenomic testing -- Ethical issues to consider when using pharmacogenomic testing in psychiatric practice -- The future development of psychiatric pharmacogenomic testing.
9780195367294 (alk. paper) 0195367294 (alk. paper)
2009027407
GBB011488 bnb
Psychotropic drugs.
Pharmacogenomics.
Biotransformation--genetics.
Psychotropic Drugs--adverse effects.
Mental Disorders--drug therapy.
Psychotropic Drugs--pharmacokinetics.
RM315 / .M73 2010 RM315 / .M73 2010
615.788 / MDP
QV 38 / M939p 2010
Psychiatric pharmacogenomics / David A. Mrazek. - New York : Oxford University Press, 2010. - x, 265 p. : ill. (some col.) ; 25 cm.
Includes bibliographical references and index.
The language of molecular genetics -- The fourteen genes -- The problem and the solution -- The cytochrome P450 2D6 gene -- The cytochrome P450 2C19 gene -- The cytochrome P450 2C9 gene -- The cytochrome P450 1A2 gene -- The catechol-o-methyltransferase gene -- The norepinephrine transporter gene -- The dopamine transporter gene -- The serotonin transporter gene -- The serotonin 1A receptor gene -- The serotonin 2A receptor gene -- The serotonin 2C receptor gene -- The dopamine D2 receptor gene -- The dopamine D3 receptor gene -- The dopamine D4 receptor gene -- The clinical utility of psychiatric pharmacogenomic testing -- Ethical issues to consider when using pharmacogenomic testing in psychiatric practice -- The future development of psychiatric pharmacogenomic testing.
9780195367294 (alk. paper) 0195367294 (alk. paper)
2009027407
GBB011488 bnb
Psychotropic drugs.
Pharmacogenomics.
Biotransformation--genetics.
Psychotropic Drugs--adverse effects.
Mental Disorders--drug therapy.
Psychotropic Drugs--pharmacokinetics.
RM315 / .M73 2010 RM315 / .M73 2010
615.788 / MDP
QV 38 / M939p 2010